Bioventus (BVS) Minority Interest (2021 - 2026)

Bioventus (BVS) has reported Minority Interest for 6 consecutive years, with $49.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest rose 22.59% year-over-year to $49.1 million; the trailing twelve-month figure through Jun 2026 stood at $49.1 million (up 22.59% YoY), and the FY2025 full-year result was $44.3 million, up 17.73% from the prior year.
• Minority Interest rose to $49.1 million in Q2 2026 per BVS's latest filing, from $45.4 million in the prior quarter.
• Across five years, Minority Interest topped out at $87.0 million in Q4 2022 and bottomed at $35.7 million in Q4 2022.
• Historically, Minority Interest has averaged $49.1 million across 5 years, with a median of $45.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Minority Interest slumped 54.16% in 2022, then soared 36.86% in 2023.
• Over 5 years, Minority Interest stood at $87.0 million in 2022, then sank by 45.36% to $47.5 million in 2023, then declined by 20.75% to $37.7 million in 2024, then gained by 17.73% to $44.3 million in 2025, then grew by 10.74% to $49.1 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $49.1 million, $45.4 million, and $44.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.